Application 021183
- Type
- NDA
- Sponsor
- BRISTOL MYERS SQUIBB
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 125MG | Yes | No |
| 002 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 200MG | Yes | No |
| 003 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 250MG | Yes | No |
| 004 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 400MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0087-6671 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6671 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6671 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6672 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6672 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6672 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6673 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6673 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6673 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6674 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6674 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6674 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |